Rankings
▼
Calendar
NAUT FY 2018 Earnings — Nautilus Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena
NAUT
Nautilus Biotechnology, Inc.
$289M
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$112M
Net Income
$627M
EPS (Diluted)
$87.18
Cash Flow
Operating Cash Flow
-$238M
Free Cash Flow
-$238M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$146M
Total Liabilities
$141M
Stockholders' Equity
$5M
Cash & Equivalents
$1M
← Q4 2018
All Quarters